Neonatal-onset multisystem inflammatory disease

Neonatal-onset multisystem inflammatory disease (NOMID), also known as Chronic Infantile Neurological Cutaneous and Articular syndrome (CINCA), is a rare genetic disorder that affects multiple systems of the body. This condition is characterized by a triad of symptoms: skin rash, joint involvement, and chronic meningitis.

Symptoms and Signs[edit | edit source]

The symptoms of NOMID usually appear shortly after birth. The most common symptom is a skin rash that typically appears within the first six weeks of life. Other symptoms may include fever, joint pain, and inflammation of the membranes surrounding the brain and spinal cord (meningitis). In some cases, individuals with NOMID may also experience hearing loss, vision problems, and developmental delays.

Causes[edit | edit source]

NOMID is caused by mutations in the NLRP3 gene. This gene provides instructions for making a protein that is involved in the body's immune response. Mutations in the NLRP3 gene lead to continuous activation of the immune system, resulting in widespread inflammation and the symptoms of NOMID.

Diagnosis[edit | edit source]

Diagnosis of NOMID is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and specialized tests. Genetic testing can confirm a diagnosis.

Treatment[edit | edit source]

Treatment of NOMID is aimed at managing symptoms and preventing complications. This may include medications to reduce inflammation and pain, physical therapy to improve joint mobility, and regular monitoring for potential complications.

Prognosis[edit | edit source]

The prognosis for individuals with NOMID varies. With early diagnosis and appropriate treatment, many individuals with NOMID can lead productive lives. However, without treatment, NOMID can lead to severe complications, including disability and premature death.